Vanguard Capital Management’s Kestra Medical Technologies KMTS Stock Holding History
Bought
Maintained
Sold
Other funds holding KMTS
YF
Vanguard Capital Management's KMTS Position: Q3 2026 in Review
Vanguard Capital Management increased its Kestra Medical Technologies (KMTS) stake by 13% in Q3 2026, buying an estimated $3.93M and bringing the position to 1,329,644 shares worth $37.6M. The position accounts for ﹤0.01% of the portfolio, ranked #2049.
Vanguard Capital Management first reported a position in KMTS in Q1 2026 and has held it in 3 quarters since. 122 funds tracked by Wall St. Rank hold KMTS as of Q3 2026.
- Vanguard Capital Management held 1,329,644 shares of Kestra Medical Technologies worth $37.6M as of Q3 2026.
- Vanguard Capital Management bought 154,119 Kestra Medical Technologies shares in Q3 2026, an estimated $3.93M.
- Kestra Medical Technologies made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #2049 holding.
- Vanguard Capital Management first reported a position in Kestra Medical Technologies in Q1 2026 and has held it in 3 quarters since.
- 122 funds tracked by Wall St. Rank held Kestra Medical Technologies as of Q3 2026.
Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.